Login

VALEANT PHARMACEUTICALS INTERNATIONAL 3 SEC Filings

Filed On Filing
21 Dec 2009 Form 3: Boze Brandon, Director

No securities owned

01 Apr 2009 Form 3: Stefano Stephen F., Director

No securities owned

19 Mar 2009 Form 3: Chaudhuri Bhaskar, President

No securities owned

13 Jan 2009 Form 3: Lonner Anders, Director

No securities owned

13 Jan 2009 Form 3: De Silva Rajiv, Chief Operating Officer

No securities owned

29 Jul 2008 Form 3: HealthCor Management, L.p., 10% owner and 8 others

Holds 8,500,000 shares of Common Stock, par value $0.01 per share

02 Jul 2008 Form 3: Min Steve T., EVP, General Counsel and
22 May 2008 Form 3: Karlson Elisa A., EVP & CHIEF ADMINISTRATIVE OFF
05 Feb 2008 Form 3: Pearson J. Michael, Director

No securities owned

19 Nov 2007 Form 3: ValueAct Holdings, L.p., 10% owner and 2 others

Holds 11,857,600 shares of Common Stock, par value $.01 per share

24 May 2007 Form 3: Provencio Norma Ann, Director

No securities owned

09 May 2007 Form 3: Morfit G Mason, Director

No securities owned

28 Mar 2007 Form 3: Blott Peter J, EVP & CFO

Holds 1,000 shares of Common Stock

18 Jul 2006 Form 3: Va Partners Llc, 10% owner and 4 others

Holds 9,465,100 shares of Common Stock, par value $.01 per share

11 Jan 2005 Form 3: Wheeler Wesley, President, North American Reg

Holds 1,446 shares of Common Stock

11 Jan 2005 Form 3: Cooper John, EVP, Global Manufac and Supply

Holds 5,420 shares of Common Stock

11 Jan 2005 Form 3: Bramlage Charles, President, European Operations
26 May 2004 Form 3: Ullian Elaine, Director

Holds 500 shares of Common Stock

04 Feb 2004 Form 3: Lamon Kim David, Pres and Chief Scientific Off

No securities owned

28 May 2003 Form 3: Melas Kyriazi Theo, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support